游戏里的战斗激情,免费无码毛片一区二区A片小说 ,忍着娇喘人妻被中出中文字幕,中文字幕在线亚洲二区

普羅吉生物 Protgen
北京普羅吉生物科技發(fā)展有限公司 (Protgen Ltd.) 成立于 2004 年 8 月，是由留學(xué)歸國(guó)人員創(chuàng)立的研發(fā)型高新技術(shù)企業(yè)。公司的研發(fā)及高層管理團(tuán)隊(duì)由多位留學(xué)歐美的資深學(xué)者和企業(yè)家組成，具有豐富的重組蛋白藥物研發(fā)和生物技術(shù)公司管理運(yùn)行經(jīng)驗(yàn)。目前，公司員工本科以上學(xué)歷達(dá)到 90% 以上，其中擁有博士和碩士學(xué)位的達(dá) 40% 以上。

普羅吉公司，是國(guó)家發(fā)展和改革委員會(huì)批準(zhǔn)建立的 “抗腫瘤蛋白質(zhì)藥物國(guó)家工程實(shí)驗(yàn)室” 的共建單位，與清華大學(xué)有著密切合作，建立了高效和日趨成熟的產(chǎn)、學(xué)、研相結(jié)合的生物技術(shù)成果快速轉(zhuǎn)化機(jī)制和模式。公司致力于研發(fā)具有自主知識(shí)產(chǎn)權(quán)和國(guó)際競(jìng)爭(zhēng)力的重組蛋白質(zhì)藥物、抗體藥物和腫瘤診斷試劑，在蛋白質(zhì)藥物規(guī)模化制備方面具有一系列國(guó)際領(lǐng)先的核心專有技術(shù)。

公司具有卓越的科研項(xiàng)目管理經(jīng)驗(yàn)和先進(jìn)的技術(shù)研發(fā)水平，承擔(dān)并參與了多項(xiàng)國(guó)家級(jí)科研課題?！笆濉逼陂g公司參與完成國(guó)家 863 課題一項(xiàng)，目前正承擔(dān)一項(xiàng) 863 課題，并參與一項(xiàng) 863 課題，主持“十一五”計(jì)劃“重大新藥創(chuàng)制”一項(xiàng)，參與“十一五”計(jì)劃“重大新藥創(chuàng)制”兩項(xiàng)。公司已申請(qǐng)了五項(xiàng) PCT 發(fā)明專利，分別進(jìn)入四十一個(gè)國(guó)家和地區(qū)，其中一項(xiàng)已在中國(guó)獲得授權(quán)。

長(zhǎng)期以來(lái)，公司受到了北京市委、市政府，北京市科委及中關(guān)村管委會(huì)等部門的大力支持。公司首席科學(xué)家入選中央 2009 年度第一批“千人計(jì)劃”；2010 年 4 月，公司榮獲中關(guān)村國(guó)家自主創(chuàng)新示范區(qū)“2009 年重大科技成果產(chǎn)業(yè)化突出貢獻(xiàn)單位”稱號(hào)；同年，公司成為“北京生物醫(yī)藥產(chǎn)業(yè)跨越發(fā)展工程”（G20工程）第一批企業(yè)，并入選 2010 年中關(guān)村“瞪羚計(jì)劃”首批重點(diǎn)培育企業(yè)。

公司力爭(zhēng)在未來(lái)五年內(nèi)，發(fā)揮重組蛋白規(guī)?；苽浜偷鞍踪|(zhì)藥物研發(fā)的優(yōu)勢(shì)，面向海內(nèi)外生物醫(yī)藥市場(chǎng)，努力發(fā)展成為國(guó)內(nèi)一流、國(guó)際知名的生物制藥公司。


Protgen Ltd., as a new research high-technology company located in the Zhongguancun Science and Technology Park, was founded in August, 2004 by returned oversea scholars. The senior management team, who are in charge of the R & D and management, consist of several oversea scholars and enterprisers. At present, 90% employees of the company have bachelor degrees and 40% of them have doctoral degrees.

Located in the Zhongguancun Biomedical Park, Protgen Ltd. is the collaborator of the National Engineering Laboratory for Anti-tumor Protein Therapeutics authorized by the National Develop and Reform Commission. Protgen dedicates in developing recombinant protein drugs with intellectual property rights and international competitiveness, protein drugs, antibodies, diagnosis kits and service on recombinant proteins (protein purification, refolding; antibody preparation protein drug production).

Protgen believes efficiency, seriouseness, deploitation and innovation. According to our excellent project experience, Protgen has been participating many national science projects, such as 863, etc. Now Protgen has filed 4 PCT inventions and patents, one of which has been authorized in China.

Protgen is supported by many government departments. The chief scientist is selected to the “One-Thousand Talent Project”. On 23th April, Protgen is announced to be one of the G20 enterprises.

In the next five years, based on its advantages in protein science, Protgen will explore and seek for oversea market and make its best to become an internationally well-known biomedical company.